My SciELO
Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Revista de la OFIL
On-line version ISSN 1699-714XPrint version ISSN 1131-9429
Abstract
CANTARELLI, L; GUTIERREZ, NF; NAZCO-CASARIEGO, GJ and GONZALEZ-GARCIA, J. Incidence of hypokalemia in patients with febrile neutropenia receiving treatment with liposomal amphotericin B. Rev. OFIL·ILAPHAR [online]. 2022, vol.32, n.3, pp.263-266. Epub Sep 25, 2023. ISSN 1699-714X. https://dx.doi.org/10.4321/s1699-714x2022000300009.
Objectives:
To describe the incidence, severity and factors associated with the appearance of hypokalemia in patients with febrile neutropenia in treatment with liposomal amphotericin B.
Methods:
Retrospective unicenter study (January 2010-May 2020), which included those hematological patients with febrile neutropenia who were treated with liposomal amphotericin B for at least 72 h. The incidence of hypokalemia associated with the use of the drug, itsseverity, and the influence of potassiumsupplementation on the occurrence ofhypokalemia in this group of patientswere evaluated.
Results:
89 patients were included (50.6% women [n=45]; mean age 63.5 years [20-90]). 59.6% (n=53) of patients developed hypokalemia during treatment with liposomal amphotericin B: mild (52.8%, n=28), moderate (35.8%, n=19) and severe (11.3%, n=6). The use of early-onset potassium-based supplementation decreased the rate of occurrence of hypokalemia in these patients (p=0.001). The period between drug initiation and potassium intake was lower in patients who did not develop hypokalemia (p<0.001). Likewise, this group of patients benefited from longer periods of supplementation (p=0.002) and antifungal therapy (p=0.039).
Conclusions:
Hypokalemia is a very frequent adverse effect in patients with febrile neutropenia who are treated with liposomal amphotericin B. It is necessary to establish protocols for potassium supplementation to reduce the risk of this adverse reaction.
Keywords : Hypokalemia; febrile neutropenia; liposomal amphotericin B; antifungal agents; adverse effects.